Table 1 Clinical baseline data grouped according to different glucose metabolic status
| Â | NGR | Pre-DM | DM | P |
|---|---|---|---|---|
(n = 139) | (n = 218) | (n = 324) | ||
Age (years) | 59.37 ± 9.49 | 59.57 ± 9.86 | 60.06 ± 10.42 | 0.747 |
Male (n, %) | 116 (83.5%) | 171 (78.4%) | 243 (75.0%) | 0.129 |
SBP (mmHg) | 134.06 ± 17.77 | 133.67 ± 18.88 | 133.09 ± 16.73 | 0.106 |
DBP (mmHg) | 79.68 ± 12.52 | 78.23 ± 11.72 | 78.46 ± 10.45 | 0.101 |
Smoking history (n, %) | 55 (39.6%) | 55 (43.6%) | 135 (41.7%) | 0.752 |
Drinking history (n, %) | 53 (23.3%) | 63 (27.8%) | 59 (26.0%) | 0.731 |
History of hypertension (n, %) | 84 (60.4%) | 120 (55.0%) | 198 (61.1%) | 0.346 |
Previous medication | ||||
 Antihypertensive drugs (n, %) | 83 (59.7%) | 119 (54.6%) | 191 (59.0%) | 0.521 |
 Lipid-lowering drugs (n, %) | 133 (95.7%) | 205 (94.0%) | 310 (95.7%) | 0.648 |
 Antiplatelet drugs (n, %) | 129 (92.8%) | 201 (92.2%) | 300 (92.6%) | 0.975 |
 Antidiabetic drugs (n, %) | 9 (6.5%) | 27 (12.4%) | 166 (51.2%) | < 0.001* |
Laboratory examination | ||||
 cTnI (ng/mL) | 0.010 (0.010–0.020) | 0.010 0.010–0.020) | 0.010 (0.010–0.020) | 0.425 |
 BNP (pg/mL) | 131.79 ± 61.11 | 128.03 ± 56.08 | 130.85 ± 59.81 | 0.821 |
 Cr (μmol/L) | 70.16 ± 12.83 | 70.23 ± 13.68 | 68.47 ± 14.53 | 0.592 |
 eGFR (mL/min/1.73 m2) | 92.03 ± 12.19 | 93.28 ± 12.67 | 68.47 ± 14.53 | 0.470 |
 CRP (mg/L) | 1.26 (0.74–1.83) | 1.34(0.77–1.90) | 1.32 (0.78–1.83) | 0.668 |
 TC (mg/dL) | 3.36 (2.88–3.91) | 3.58(3.00–4.29) | 3.54 (3.09–4.22) | 0.083 |
 TG (mg/dL) | 1.22 (0.90–1.75) | 1.38(1.03–1.81) | 1.56 (1.10–2.11) | < 0.001* |
 HDL-C (mg/dL) | 0.96 (0.82–1.15) | 0.91 (0.79–1.05) | 0.90 (0.78–1.04) | 0.010* |
 LDL-C (mg/dL) | 1.97 (1.57–2.42) | 2.07 (1.65–2.64) | 2.10 (1.66–2.61) | 0.118 |
 FPG (mmol/L) | 4.60 (4.25–5.05) | 5.01 (4.57–5.46) | 7.20 (6.01–9.05) | < 0.001* |
 HbA1c (%) | 5.40 (5.30–5.50) | 6.00 (5.80–6.20) | 7.60 (6.90–9.00) | < 0.001* |
 LVEF (%) | 61.00 (57.50–64.00) | 61.00 (52.00–63.00) | 61.00 (52.00–64.00) | 0.312 |
 TyG index | 8.43 (8.06–8.81) | 8.63 (8.37–8.89) | 9.11 (8.70–9.52) | < 0.001* |
Number of vascular stenosis | ||||
 1 | 17 (12.2%) | 21 (9.6%) | 24 (7.4%) | 0.580 |
 2 | 33 (23.7%) | 52 (23.9%) | 81 (25%) |  |
 3 | 89 (64.1%) | 145 (66.5%) | 219 (67.6%) |  |
CTO related artery | ||||
 LAD | 64 (38.1%) | 95 (34.3%) | 138 (34.5%) | 0.784 |
 LCX | 36 (21.4%) | 69 (24.9%) | 105 (26.3%) |  |
 RCA | 68 (40.5%) | 113 (40.8%) | 157 (39.3%) |  |
Rentrop collateral grading | ||||
 0 | 5 (3.6%) | 11 (5.0%) | 38 (11.7%) | < 0.001* |
 1 | 19 (13.7%) | 31 (14.2%) | 101 (31.2%) |  |
 2 | 47 (33.8%) | 86 (39.4%) | 121 (37.3%) |  |
 3 | 68 (48.9%) | 90 (41.3%) | 64 (19.8%) |  |